AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22136317 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day)
Number of subjects: 97
Study 22136317 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 97
Study 20638919 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based prevention program, Trouble on the Tightrope: In Search of Skateboard Sam
Number of subjects: 190
Study 20638919 — intervention group
Group type: COMPARATOR
Intervention: Attention placebo control condition
Number of subjects: 190
Study 17620970 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60 mg once daily
Number of subjects: 7665
Study 17620970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7665
Study 15285036 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of regular insulin (20 U) followed by glucose infusion (500 mL 50 g/L dextrose)
Number of subjects: 16
Study 15285036 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 16
Study 15285036 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of regular insulin (20 U)
Number of subjects: 16
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO criteria for blindness (best-corrected visual acuity worse than 0.05)
Number of subjects: 1000
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: National criteria for blindness (best-corrected visual acuity of 0.1 or worse)
Number of subjects: 1000
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related macular degeneration (AMD)
Number of subjects: 1000
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: Glaucoma, myopic macular degeneration, cataract, retinitis pigmentosa
Number of subjects: 1000
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: Amblyopia
Number of subjects: 1000
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic retinopathy
Number of subjects: 1000
Study 11594976 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1000
Study 9597405 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (a low molecular weight heparin)
Number of subjects: 256
Study 8270968 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 490
Study 8270968 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy maintenance regimens (continuous vs cyclic)
Number of subjects: 490
Study 2643934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (2 micrograms/kg)
Number of subjects: 30
Study 2643934 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine (flexible-dose treatment for averaging ten weeks)
Number of subjects: 30
Study 2643934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 4613812 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 24
Study 4613812 — intervention group
Group type: COMPARATOR
Intervention: Control (no phototherapy)
Number of subjects: 24
Study 30454014 — intervention group
Group type: COMPARATOR
Intervention: Conventional neurorehabilitation (control)
Number of subjects: 70
Study 30454014 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel self-management intervention (8 sessions of 45-60 min by physiotherapist or occupational therapist over 9 months)
Number of subjects: 70
Study 30454014 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 70
Study 28844358 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine inquiry about violence victimization
Number of subjects: 15
Study 28844358 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine inquiry about alcohol consumption
Number of subjects: 15
Study 28844358 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking about violence
Number of subjects: 15
Study 25542267 — intervention group
Group type: EXPERIMENTAL
Intervention: Onartuzumab with weekly paclitaxel
Number of subjects: 185
Study 25542267 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo plus bevacizumab plus paclitaxel)
Number of subjects: 185
Study 23855167 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine
Number of subjects: 60
Study 23855167 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% calcium hydroxide
Number of subjects: 60
Study 23855167 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% Dimethyl Sulfoxide (DMSO) extract of propolis
Number of subjects: 60
Study 23855167 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study 20861645 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus L-92
Number of subjects: 0
Study 20861645 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (topical application of a steroid ointment)
Number of subjects: 0
Study 18502235 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpeas (728 g/week for 12 weeks)
Number of subjects: 45
Study 18502235 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (without chickpeas for 4 weeks)
Number of subjects: 45
Study 16979407 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic exercise 3 to 4 days per week for 6 months at 70% to 85% maximal heart rate for 45 to 60 minutes per session)
Number of subjects: 47
Study 16979407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 47
Study 16979407 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training and Control group (AA women)
Number of subjects: 47
Study 16979407 — intervention group
Group type: COMPARATOR
Intervention: Control group (CA women)
Number of subjects: 47
Study 12171084 — intervention group
Group type: EXPERIMENTAL
Intervention: CABLES model
Number of subjects: 0
Study 10511348 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate (50-140 microg/day)
Number of subjects: 625
Study 10511348 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate (50-250 microg/day)
Number of subjects: 625
Study 10511348 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate (50-400 microg/day)
Number of subjects: 625
Study 10511348 — intervention group
Group type: COMPARATOR
Intervention: Transdermal E2 (50 microg/day)
Number of subjects: 625
Study 10511348 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 625
Study 10511348 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate
Number of subjects: 625
Study 7747857 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam 0.2 mg.kg‐1
Number of subjects: 3
Study 7747857 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg.kg‐1
Number of subjects: 3
Study 7747857 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.3 mg.kg‐1
Number of subjects: 3
Study 2252771 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 hr HD with high blood flow
Number of subjects: 23
Study 2252771 — intervention group
Group type: COMPARATOR
Intervention: 4 hr HD with slow blood flow
Number of subjects: 23
Study 2252771 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration volume
Number of subjects: 23
Study 2252771 — intervention group
Group type: COMPARATOR
Intervention: Type of membrane (Cuprophan, Hemophan, Polyamide)
Number of subjects: 23
Study 6999128 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline chloride
Number of subjects: 14
Study 6999128 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 14
Study 31425577 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel treatment for 6 weeks
Number of subjects: 45
Study 31425577 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel treatment for 6 weeks
Number of subjects: 45
Study 29800234 — intervention group
Group type: EXPERIMENTAL
Intervention: ReCell® Autologous Cell Harvesting Device (ASCS)
Number of subjects: 100
Study 29800234 — intervention group
Group type: COMPARATOR
Intervention: Meshed split-thickness skin grafts (STSG)
Number of subjects: 100
Study 28558718 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic-fermented egg white (LE) with 8 g of protein daily for 8 weeks
Number of subjects: 88
Study 28558718 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic-fermented egg white (LE) with 4 g of protein daily for 8 weeks
Number of subjects: 88
Study 26180474 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL) with riboflavin drops and ultraviolet radiation
Number of subjects: 26
Study 26180474 — intervention group
Group type: COMPARATOR
Intervention: Control group (contralateral eye)
Number of subjects: 26
Study 26180474 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL)
Number of subjects: 26
Study 23869655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion (ILE)
Number of subjects: 64
Study 23869655 — intervention group
Group type: COMPARATOR
Intervention: Supportive care (Control)
Number of subjects: 64
Study 23450080 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered empowerment model
Number of subjects: 86
Study 23450080 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study 18978628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive combined training program (10 weeks, 4 times a week)
Number of subjects: 24
Study 18978628 — intervention group
Group type: COMPARATOR
Intervention: Technical training (control group)
Number of subjects: 24
Study 17165503 — intervention group
Group type: EXPERIMENTAL
Intervention: Turtle-probing needling at Tianzhu (BL 10)
Number of subjects: 70
Study 17165503 — intervention group
Group type: COMPARATOR
Intervention: Routine needling at Fengchi (GB 20), Tianzhu (BL 10), Shuaigu (GB 8), Touwei (ST 8), and corresponding cervical Jiaji points (EX-B2), Houxi (SI 3), Ashi points
Number of subjects: 70
Study 12715585 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology (6 sessions of 30 minutes each)
Number of subjects: 50
Study 12715585 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 50
Study 10884634 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt and soda mouthwash
Number of subjects: 200
Study 10884634 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 200
Study 10884634 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic mouthwash (lidocaine, Benadryl, and Maalox)
Number of subjects: 200
Study 9226551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary capillary‐zone electrophoresis (CZE)
Number of subjects: 0
Study 9226551 — intervention group
Group type: EXPERIMENTAL
Intervention: SDS‐CZE
Number of subjects: 0
Study 9226551 — intervention group
Group type: EXPERIMENTAL
Intervention: CIEF
Number of subjects: 0
Study 8080420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream
Number of subjects: 28
Study 8080420 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 28
Study 2890520 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (beta 1)
Number of subjects: 9
Study 2890520 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol (beta 1/2)
Number of subjects: 9
Study 2890520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2890520 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol vs Oxprenolol
Number of subjects: 9
Study 2890520 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 9
Study 2890520 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 9
Study 29325967 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 90
Study 29325967 — intervention group
Group type: COMPARATOR
Intervention: Control group (no binder)
Number of subjects: 90
Study 27602968 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling followed by Levulan PDT
Number of subjects: 20
Study 27602968 — intervention group
Group type: COMPARATOR
Intervention: PDT alone (Levulan without microneedling)
Number of subjects: 20
Study 24243316 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline 50 mg q12h
Number of subjects: 76
Study 24243316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 22445776 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK598809 (dopamine D3 receptor antagonist)
Number of subjects: 0
Study 22445776 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 19837118 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain wheat bread (WWB)
Number of subjects: 16
Study 19837118 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat pasta (RWP)
Number of subjects: 16
Study 19837118 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain wheat pasta (WWP)
Number of subjects: 16
Study 19837118 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat bread (RWB)
Number of subjects: 16
Study 18455203 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues indicating object weight
Number of subjects: 0
Study 18455203 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory cues indicating object weight
Number of subjects: 0
Study 18455203 — intervention group
Group type: COMPARATOR
Intervention: No cue about the weight of the object
Number of subjects: 0
Study 16020820 — intervention group
Group type: EXPERIMENTAL
Intervention: Involuntary psychiatric examinations initiated by law enforcement officials
Number of subjects: 130
Study 11960044 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic retropubic urethropexy using nonabsorbable sutures (group A)
Number of subjects: 60
Study 11960044 — intervention group
Group type: COMPARATOR
Intervention: Transperitoneal laparoscopic retropubic urethropexy using polypropylene mesh fixed with tacks or staples (group B)
Number of subjects: 60
Study 9822993 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral psychotropic medications with clubhouse program attendance
Number of subjects: 0
Study 9822993 — intervention group
Group type: COMPARATOR
Intervention: Injectable neuroleptic regimens with clubhouse program attendance
Number of subjects: 0
Study 9822993 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial rehabilitation clubhouses
Number of subjects: 0
Study 8107739 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (15 mg/kg, max 1000 mg)
Number of subjects: 36
Study 8107739 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 36
Study 2779692 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (2 mg)
Number of subjects: 23
Study 2779692 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (3 mg)
Number of subjects: 23
Study 2779692 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone sodium phosphate (30 mg)
Number of subjects: 23
Study 787960 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicyclomine
Number of subjects: 0
Study 787960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7029838 — intervention group
Group type: EXPERIMENTAL
Intervention: SHRZ/HRZ (6 months)
Number of subjects: 330
Study 7029838 — intervention group
Group type: EXPERIMENTAL
Intervention: SHRZ/HR (6 months)
Number of subjects: 330
Study 7029838 — intervention group
Group type: EXPERIMENTAL
Intervention: SHRZ/HRZ (4 months)
Number of subjects: 330
Study 7029838 — intervention group
Group type: EXPERIMENTAL
Intervention: SHRZ/HR (4 months)
Number of subjects: 330
Study 7029838 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacilli resistant to isoniazid or streptomycin (6 months)
Number of subjects: 330
Study 7029838 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacilli resistant to isoniazid or streptomycin (4 months)
Number of subjects: 330
Study 31397077 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (single dose prior to surgery)
Number of subjects: 206
Study 31397077 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics (no preoperative and postoperative antibiotics)
Number of subjects: 206
Study 28010953 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg daily)
Number of subjects: 0
Study 28010953 — intervention group
Group type: COMPARATOR
Intervention: No statins (control group)
Number of subjects: 0
Study 26070226 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic-guided pertubal diluted bupivacaine infusion (0.25%)
Number of subjects: 60
Study 26070226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24605899 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1,500 mg daily
Number of subjects: 35
Study 22622912 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal epidural injections with local anesthetic and steroids
Number of subjects: 27
Study 22622912 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetics alone
Number of subjects: 27
Study 22622912 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic with or without steroids
Number of subjects: 27
Study 19211170 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 J/cm2 UVA1 phototherapy
Number of subjects: 16
Study 19211170 — intervention group
Group type: COMPARATOR
Intervention: 20 J/cm2 UVA1 phototherapy
Number of subjects: 16
Study 19211170 — intervention group
Group type: COMPARATOR
Intervention: No irradiation (control)
Number of subjects: 16
Study 17405163 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal caffeine consumption (moderate intake)
Number of subjects: 4196
Study 17405163 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal caffeine consumption (high intake)
Number of subjects: 4196
Study 17405163 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee intake
Number of subjects: 4196
Study 17405163 — intervention group
Group type: COMPARATOR
Intervention: Control group (no caffeine consumption)
Number of subjects: 4196
Study 15345731 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical Impedance Analysis (BIA) measuring intracellular water (ICW), extracellular water (ECW), and total body water (TBW) on four occasions (baseline, days 7, 14, and 28)
Number of subjects: 313
Study 15345731 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood urea nitrogen/creatinine ratios greater than 21:1
Number of subjects: 313
Study 15345731 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium measured with NEECHAM Confusion Scale, Vigilance score, Mini-Mental Status Examination, and Confusion Assessment Method
Number of subjects: 313
Study 15345731 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA measures
Number of subjects: 313
Study 11933032 — intervention group
Group type: EXPERIMENTAL
Intervention: Selection modelling framework
Number of subjects: 0
Study 11933032 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern-mixture models
Number of subjects: 0
Study 9701186 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) diet for 16 days
Number of subjects: 25
Study 9701186 — intervention group
Group type: COMPARATOR
Intervention: High-Fat (HF) diet for 16 days
Number of subjects: 25
Study 7917149 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (180 to 480 mg/day)
Number of subjects: 15
Study 2668133 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL with a laser ridge
Number of subjects: 100
Study 2668133 — intervention group
Group type: COMPARATOR
Intervention: IOL without a laser ridge
Number of subjects: 100
Study 2668133 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 1199816 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa administered as a solution
Number of subjects: 20
Study 1199816 — intervention group
Group type: COMPARATOR
Intervention: L-dopa administered in tablet form
Number of subjects: 20
Study 1199816 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric meals (rich in protein or carbohydrate)
Number of subjects: 20
Study 1199816 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa administered at short intervals
Number of subjects: 20
Study 30244489 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intercostal nerve block
Number of subjects: 38
Study 30244489 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided epidural nerve block
Number of subjects: 38
Study 28870648 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation system for maxillary repositioning
Number of subjects: 5
Study 28870648 — intervention group
Group type: COMPARATOR
Intervention: Splint transposed control group
Number of subjects: 5
Study 24750359 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated 24‐h international travel (INT)
Number of subjects: 10
Study 24750359 — intervention group
Group type: COMPARATOR
Intervention: Control trial (CON)
Number of subjects: 10
Study 24459762 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive thyroidectomy (MIT)
Number of subjects: 48
Study 24459762 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 48
Study 24459762 — intervention group
Group type: COMPARATOR
Intervention: Both MIT and MIVAT
Number of subjects: 48
Study 22196471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Cannula (NC; 0.5 L/kg/min)
Number of subjects: 75
Study 22196471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Prongs with Continuous Positive Airway Pressure (NP-CPAP; 5-10 L/min, pressure 5 cmH(2)O)
Number of subjects: 75
Study 22196471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal Catheter (NPC; 0.3-0.5 L/kg/min)
Number of subjects: 75
Study 19193738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 28
Study 19193738 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 28
Study 19193738 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin
Number of subjects: 28
Study 19193738 — intervention group
Group type: COMPARATOR
Intervention: Control (no immunosuppressive treatment)
Number of subjects: 28
Study 17530971 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise performed 14 hours before carbohydrate ingestion
Number of subjects: 10
Study 17530971 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 10
Study 15195855 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole sodium (20 mg single dose)
Number of subjects: 12